Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: 7 Day Continuous Parathyroid Hormone IV Infusion [EARLY_Phase 1]
An early-phase trial evaluated a 7-day continuous intravenous infusion of parathyroid hormone. The trial focused on osteoporosis and hyperpa…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery? [Phase 2]
A Phase 2 trial update assessing whether a systematic treatment improves calcium and bone metabolism following surgery for primary hyperpara…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study [EARLY_Phase 1]
A one-week intravenous dose-escalation Phase 1 study of parathyroid hormone-related protein (PTHrP) completed, with results posted in 2016.
-
FDA approval · 2016-02-04FDA Approved: PARICALCITOL — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s paricalcitol under its original application NDA207174 for the treatment of secondary hyperparathyroid…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients [Phase 3]
Phase 3 clinical trial update on treating autonomous hyperparathyroidism in post-renal transplant recipients; results completed with posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Treatment Adhesion in Dialysis Patients Treated With Cinacalcet [Phase 4]
Phase 4 clinical trial update on adherence to cinacalcet therapy in dialysis patients with hyperparathyroidism and chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT) [NA]
A completed trial update evaluating maintenance vitamin D therapy for secondary hyperparathyroidism, with results posted.
-
FDA approval · 2016-01-14FDA Approved: PARICALCITOL — Original Application (Aurobindo Pharma Limited)
The FDA approved the original application (ANDA) for paricalcitol from Aurobindo Pharma Limited. This generic paricalcitol is used to treat …
-
FDA approval · 2016-01-13FDA Approved: PARICALCITOL — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's original application for generic paricalcitol (PARICALCITOL), a vitamin D analog used to treat secondary hyperparathyr…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Active Vitamin D Effect on Left Ventricular Hypertrophy [Phase 4]
Phase 4 trial evaluating active vitamin D for left ventricular hypertrophy in patients with chronic kidney disease and secondary hyperparath…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients [NA]
A completed clinical trial evaluating ultrasonic ablation for secondary hyperparathyroidism in chronic kidney disease patients; results were…
-
CLINICAL_TRIALS withdrawal · 2015-09-21Clinical Trial Update: Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism
A multicenter registry evaluating preoperative imaging for primary hyperparathyroidism has been withdrawn.
-
CLINICAL_TRIALS research · 2015-09-18Clinical Trial Update: 11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues [Phase 2]
This document reports a Phase 2 clinical trial evaluating 11C methionine PET imaging to detect hyperfunctional parathyroid tissues in patien…
-
CLINICAL_TRIALS research · 2015-09-15Clinical Trial Update: Optimal Anemia Treatment in End Stage Renal Disease (ERSD) [NA]
This clinical trial update discusses ongoing research on optimal anemia treatment in end-stage renal disease, with a stated focus on seconda…
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: Comparison of Total Parathyroidectomy With and Without Autotransplantation [Phase 3]
Phase 3 clinical trial update comparing total parathyroidectomy with and without autotransplantation for secondary hyperparathyroidism. Stat…
-
FDA approval · 2015-08-18FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
The FDA approved AbbVie’s supplemental application for ZEMPLAR (paricalcitol). The action updates the labeling and/or indications for this p…
-
FDA approval · 2015-05-27FDA Approved: PARICALCITOL — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for PARICALCITOL from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Evaluation of Colecalciferol Substitution in Dialysis Patients [NA]
Completed clinical trial evaluating colecalciferol substitution in dialysis patients with chronic kidney disease and secondary hyperparathyr…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients. [Phase 2]
A Phase 2 trial evaluating calcium dialysate at 1.25 mmol/L for mineral metabolism in haemodialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Pediatric Chronic Kidney Disease Safety and Efficacy [Phase 3]
Phase 3 pediatric trial of a therapy for chronic kidney disease with secondary hyperparathyroidism was terminated; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism [Phase 4]
The document summarizes a completed Phase 4 study evaluating safety and efficacy of doxercalciferol in patients with chronic kidney disease …
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection [Phase 4]
A Phase 4 trial update evaluating how to dose Hectorol capsules when converting from Zemplar injections for Secondary Hyperparathyroidism; t…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis [Phase 4]
Phase 4 pharmacokinetic study evaluating Hectorol and Zemplar injections in CKD patients on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation [Phase 4]
This Phase 4 trial comparing parathyroidectomy to cinacalcet for secondary hyperparathyroidism after kidney transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism [Phase 4]
A Phase 4 trial evaluated the efficacy of cinacalcet in controlling primary hyperparathyroidism, and the study is reported as completed.